- Home
- TCMD vs ABEO Comparison
TCMD vs ABEO Comparison
Compare TCMD & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCMD | ABEO |
|---|---|---|
| Founded | 1995 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.1M | 281.0M |
| IPO Year | 2016 | 1980 |
Fundamental Metrics
Financial Performance| Metric | TCMD | ABEO |
|---|---|---|
| Price | $29.21 | $5.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $23.25 | $18.20 |
| AVG Volume (30 Days) | 332.5K | ★ 1.2M |
| Earning Date | 02-17-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.66 | N/A |
| EPS | 0.77 | ★ 1.29 |
| Revenue | ★ $311,513,000.00 | $400,000.00 |
| Revenue This Year | $11.31 | N/A |
| Revenue Next Year | $8.83 | $1,589.77 |
| P/E Ratio | $38.69 | ★ $4.24 |
| Revenue Growth | ★ 9.28 | N/A |
| 52 Week Low | $8.61 | $3.93 |
| 52 Week High | $30.24 | $7.54 |
Technical Indicators
Market Signals| Indicator | TCMD | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 66.16 | 57.58 |
| Support Level | $29.02 | $4.80 |
| Resistance Level | $29.92 | $5.55 |
| Average True Range (ATR) | 0.92 | 0.25 |
| MACD | -0.22 | 0.03 |
| Stochastic Oscillator | 60.90 | 73.91 |
Price Performance
Historical ComparisonAbout TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.